Drugs / BCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04658680 | Feb 2021 → Mar 2026 overdue | — | Bandim Health Project | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04658680 ↗ |
| Modality | Vaccine | “0.05 ml dose Mycobacterium bovis BCG live attenuated vaccine” NCT04658680 ↗ |